Unbiased AI-powered news
2 stories related to this topic, newest first.
Substrate placeholder — needs reviewCAR-T cell therapy, originally developed for cancer treatment, is achieving more remissions in patients with autoimmune diseases. According to STAT News, this progress has prompted additional clinical trials and investments from pharmaceutical companies.
U.S. Food and Drug Administration / Wikimedia (Public domain)The U.S. Food and Drug Administration has rejected a proposal to reduce regulatory oversight for specific types of artificial intelligence devices used in healthcare. The decision maintains current approval processes for these technologies. Additional developments include a pharm…